MAGIX
gene geneOn this page
Also known as PDZXJM10FLJ21687
Summary
MAGIX (MAGI family member, X-linked, HGNC:30006) is a protein-coding gene on chromosome Xp11.23, encoding PDZ domain-containing protein MAGIX (Q9H6Y5).
At a glance
- Clinical variants (ClinVar): 70 total
- MANE Select transcript:
NM_024859
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30006 |
| Approved symbol | MAGIX |
| Name | MAGI family member, X-linked |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PDZX, JM10, FLJ21687 |
| Ensembl gene | ENSG00000269313 |
| Ensembl biotype | protein_coding |
| Entrez | 79917 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 7 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000454342, ENST00000595224, ENST00000612119, ENST00000614074, ENST00000614322, ENST00000615626, ENST00000615915, ENST00000616266, ENST00000616812, ENST00000910545
RefSeq mRNA: 4 — MANE Select: NM_024859
NM_001099681, NM_001099682, NM_001395401, NM_024859
CCDS: CCDS48106, CCDS48107, CCDS75976, CCDS94607
Canonical transcript exons
ENST00000595224 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002983203 | 49164863 | 49165090 |
| ENSE00002993416 | 49163783 | 49163929 |
| ENSE00003067407 | 49164707 | 49164789 |
| ENSE00003118143 | 49165190 | 49165361 |
| ENSE00003978352 | 49166074 | 49168774 |
| ENSE00003978353 | 49162758 | 49162938 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 85.33.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0980 / max 6.6753, expressed in 51 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196316 | 0.0980 | 51 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 85.33 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 83.70 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.48 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.31 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 82.19 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.17 | gold quality |
| body of stomach | UBERON:0001161 | 81.63 | gold quality |
| right uterine tube | UBERON:0001302 | 81.56 | gold quality |
| body of pancreas | UBERON:0001150 | 81.41 | gold quality |
| cerebellum | UBERON:0002037 | 80.02 | gold quality |
| right atrium auricular region | UBERON:0006631 | 79.97 | gold quality |
| cardiac atrium | UBERON:0002081 | 77.47 | gold quality |
| metanephros cortex | UBERON:0010533 | 76.70 | gold quality |
| stomach | UBERON:0000945 | 76.69 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.42 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 76.38 | gold quality |
| apex of heart | UBERON:0002098 | 76.28 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 76.12 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.63 | gold quality |
| minor salivary gland | UBERON:0001830 | 74.95 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.78 | gold quality |
| pancreas | UBERON:0001264 | 74.43 | gold quality |
| bronchial epithelial cell | CL:0002328 | 74.15 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.89 | gold quality |
| thyroid gland | UBERON:0002046 | 73.73 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 73.29 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.06 | gold quality |
| cingulate cortex | UBERON:0003027 | 72.96 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 72.81 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 72.76 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.77 |
| E-GEOD-110499 | yes | 5.74 |
| E-MTAB-6058 | no | 43.55 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
35 targeting MAGIX, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4650-5P | 99.98 | 64.69 | 999 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-657 | 99.48 | 66.02 | 848 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-6165 | 99.44 | 67.12 | 1389 |
| HSA-MIR-4667-3P | 99.26 | 65.45 | 1608 |
| HSA-MIR-5690 | 99.25 | 67.58 | 1012 |
| HSA-MIR-6510-5P | 99.14 | 66.59 | 1081 |
| HSA-MIR-4326 | 98.97 | 67.63 | 962 |
| HSA-MIR-412-3P | 98.86 | 66.89 | 712 |
| HSA-MIR-6754-3P | 98.84 | 66.60 | 889 |
| HSA-MIR-6887-5P | 98.56 | 68.49 | 1295 |
| HSA-MIR-6795-5P | 98.52 | 68.51 | 1277 |
| HSA-MIR-7111-3P | 97.80 | 66.75 | 1467 |
| HSA-MIR-3665 | 97.73 | 65.08 | 975 |
| HSA-MIR-6855-5P | 97.51 | 66.03 | 830 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-6869-5P | 97.17 | 67.06 | 634 |
| HSA-MIR-1306-5P | 97.11 | 64.04 | 755 |
| HSA-MIR-134-5P | 97.11 | 66.52 | 976 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | magixa | ENSDARG00000025108 |
| danio_rerio | magixb | ENSDARG00000077633 |
| mus_musculus | Magix | ENSMUSG00000031147 |
| rattus_norvegicus | Magix | ENSRNOG00000010092 |
| drosophila_melanogaster | Magi | FBGN0034590 |
| caenorhabditis_elegans | WBGENE00010444 |
Paralogs (6): MAGI3 (ENSG00000081026), GRIP2 (ENSG00000144596), MAGI1 (ENSG00000151276), SAV1 (ENSG00000151748), GRIP1 (ENSG00000155974), MAGI2 (ENSG00000187391)
Protein
Protein identifiers
PDZ domain-containing protein MAGIX — Q9H6Y5 (reviewed: Q9H6Y5)
All UniProt accessions (6): A0A087WUY6, A0A087WW28, A0A087X1L4, A0A087X263, C9J123, Q9H6Y5
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H6Y5-1 | 1 | yes |
| Q9H6Y5-2 | 2 | |
| Q9H6Y5-3 | 3 |
RefSeq proteins (4): NP_001093151, NP_001093152, NP_001382330, NP_079135* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001478 | PDZ | Domain |
| IPR030031 | MAGIX | Family |
| IPR036034 | PDZ_sf | Homologous_superfamily |
Pfam: PF00595
UniProt features (22 total): strand 6, sequence variant 4, compositionally biased region 3, helix 2, region of interest 2, splice variant 2, chain 1, domain 1, modified residue 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2DJT | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H6Y5-F1 | 61.84 | 0.24 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 272
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 56 (showing top):
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4, GTGTGAG_MIR342, TGGAAA_NFAT_Q4_01, AP2_Q6, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEN_METABOLIC_SYNDROM_NETWORK, YRCCAKNNGNCGC_UNKNOWN, MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED, chrXp11, ATF2_S_UP.V1_DN, IL2_UP.V1_UP, JAK2_DN.V1_DN, KRAS.300_UP.V1_DN, KRAS.600_UP.V1_DN, KRAS.PROSTATE_UP.V1_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
242 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MAGIX | LNX2 | Q8N448 | 370 |
| MAGIX | PEX14 | O75381 | 370 |
| MAGIX | ARL4C | P56559 | 316 |
| MAGIX | APBA3 | O96018 | 244 |
| MAGIX | GAK | O14976 | 210 |
| MAGIX | PARD6G | Q9BYG4 | 209 |
| MAGIX | PDZD11 | Q5EBL8 | 204 |
| MAGIX | DNAJC22 | Q8N4W6 | 204 |
| MAGIX | ABT1 | Q9ULW3 | 196 |
| MAGIX | MYO7B | Q6PIF6 | 192 |
| MAGIX | PARD6A | Q9NPB6 | 190 |
| MAGIX | SNTG1 | Q9NSN8 | 186 |
| MAGIX | BRD7 | Q9NPI1 | 173 |
| MAGIX | BRD9 | Q9H8M2 | 173 |
| MAGIX | JTB | O76095 | 167 |
| MAGIX | MAGI3 | Q5TCQ9 | 167 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLCO1C1 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| E6 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ABCC4 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ARHGEF16 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ASIC3 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ATP2B4 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| CYSLTR2 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DGKK | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DGKZ | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DOCK4 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FRMPD4 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| FZD7 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAGIX | TAMALIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| ORF putative E6 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| KCNA5 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| KIR3DL3 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAP2K2 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAGIX | PBK | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| RALBP1 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| RASSF6 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SLC15A5 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TJP2 | MAGIX | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| MAGIX | ERCC1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAGIX | CLUH | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (68): CDC27 (Affinity Capture-MS), CDC23 (Affinity Capture-MS), STK24 (Affinity Capture-MS), STK26 (Affinity Capture-MS), TJP1 (Affinity Capture-MS), ANAPC5 (Affinity Capture-MS), ANAPC7 (Affinity Capture-MS), MCMBP (Affinity Capture-MS), DGKH (Affinity Capture-MS), CDC16 (Affinity Capture-MS), ANAPC4 (Affinity Capture-MS), PMPCA (Affinity Capture-MS), ANAPC1 (Affinity Capture-MS), PMPCB (Affinity Capture-MS), NCAPH (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PPE3, A0A2R8Y2Y2, A0A494C0N9, A0A494C0Y3, A0A7I2V3R4, A0JNN8, A2VDX9, A5A769, A5PJP1, A6QPM6, A8MTW9, C9JTQ0, O15370, O35182, O43541, O70218, O75474, O89113, O94850, P0C7X2, P0DPE3, P28283, P37318, P37319, P70339, Q04890, Q10586, Q32PF6, Q5BLP8, Q5T230, Q5U5M8, Q5VY09, Q60925, Q6IQX8, Q6NZ36, Q6NZY7, Q6QNY0, Q6ZSJ8, Q7TNS8, Q80WY3
Diamond homologs: A0A0G2K2P5, A0A8P0N4K0, C5IAW9, F1LW30, O08721, O08722, O08747, O62683, O95049, O95185, O97758, P39447, P57105, Q07157, Q0P5E6, Q13424, Q28626, Q32LE7, Q3T0C9, Q5EBL8, Q5ZIK2, Q61234, Q6NXB2, Q6QA76, Q6R653, Q6UXZ4, Q6ZN44, Q761X5, Q7KRY7, Q7T2Z5, Q80VW5, Q86UL8, Q8IV45, Q8IZJ1, Q8JGT4, Q8K1S2, Q8K1S3, Q8K1S4, Q95168, Q9CZG9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1049 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:49163925:GGAGG:G | donor_gain | 1.0000 |
| X:49163926:GAGG:G | donor_gain | 1.0000 |
| X:49163926:GAGGG:G | donor_gain | 1.0000 |
| X:49163927:AGG:A | donor_gain | 1.0000 |
| X:49163928:GG:G | donor_gain | 1.0000 |
| X:49163928:GGG:G | donor_gain | 1.0000 |
| X:49163929:GG:G | donor_gain | 1.0000 |
| X:49163930:G:C | donor_loss | 1.0000 |
| X:49163930:G:GG | donor_gain | 1.0000 |
| X:49163931:T:A | donor_loss | 1.0000 |
| X:49164702:CCCA:C | acceptor_loss | 1.0000 |
| X:49164703:CCA:C | acceptor_loss | 1.0000 |
| X:49164705:A:AG | acceptor_gain | 1.0000 |
| X:49164706:G:GA | acceptor_gain | 1.0000 |
| X:49164706:GCT:G | acceptor_gain | 1.0000 |
| X:49163922:G:GT | donor_gain | 0.9900 |
| X:49163927:A:T | donor_gain | 0.9900 |
| X:49164699:T:G | acceptor_gain | 0.9900 |
| X:49164702:CCCAG:C | acceptor_gain | 0.9900 |
| X:49164703:CCAG:C | acceptor_gain | 0.9900 |
| X:49164704:CAGC:C | acceptor_gain | 0.9900 |
| X:49164705:AGCT:A | acceptor_gain | 0.9900 |
| X:49164705:AGCTG:A | acceptor_gain | 0.9900 |
| X:49164706:GC:G | acceptor_gain | 0.9900 |
| X:49164706:GCTG:G | acceptor_gain | 0.9900 |
| X:49164706:GCTGT:G | acceptor_gain | 0.9900 |
| X:49164785:CCCAG:C | donor_loss | 0.9900 |
| X:49164786:CCAGG:C | donor_loss | 0.9900 |
| X:49164787:CAGGT:C | donor_loss | 0.9900 |
| X:49164788:AG:A | donor_loss | 0.9900 |
AlphaMissense
2093 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:49164986:T:C | F135L | 0.983 |
| X:49164988:T:A | F135L | 0.983 |
| X:49164988:T:G | F135L | 0.983 |
| X:49165197:A:T | D172V | 0.969 |
| X:49165263:T:C | I194T | 0.966 |
| X:49165197:A:G | D172G | 0.961 |
| X:49165215:A:T | N178I | 0.961 |
| X:49165086:T:C | L168S | 0.956 |
| X:49165197:A:C | D172A | 0.951 |
| X:49165198:C:A | D172E | 0.946 |
| X:49165198:C:G | D172E | 0.946 |
| X:49165196:G:C | D172H | 0.944 |
| X:49165212:T:C | I177T | 0.944 |
| X:49164953:T:C | F124L | 0.936 |
| X:49164955:C:A | F124L | 0.936 |
| X:49164955:C:G | F124L | 0.936 |
| X:49165250:G:C | A190P | 0.936 |
| X:49164987:T:C | F135S | 0.934 |
| X:49165216:C:A | N178K | 0.932 |
| X:49165216:C:G | N178K | 0.932 |
| X:49165212:T:A | I177N | 0.928 |
| X:49165212:T:G | I177S | 0.928 |
| X:49165203:T:A | V174E | 0.921 |
| X:49165296:T:A | I205N | 0.905 |
| X:49166301:T:A | W303R | 0.905 |
| X:49166301:T:C | W303R | 0.905 |
| X:49165296:T:G | I205S | 0.900 |
| X:49165263:T:G | I194S | 0.892 |
| X:49165296:T:C | I205T | 0.889 |
| X:49165290:T:C | L203P | 0.888 |
dbSNP variants (sampled 300 via entrez): RS1000385177 (X:49161858 C>T), RS1002335630 (X:49167353 C>A), RS1002723109 (X:49169175 A>C), RS1004637469 (X:49161225 G>T), RS1009085527 (X:49162681 T>C), RS1009471471 (X:49165455 G>A), RS1009550924 (X:49162301 G>A), RS1009834305 (X:49165902 G>A,T), RS1011562875 (X:49167449 A>G), RS1013322257 (X:49165033 G>A), RS1013412698 (X:49161730 C>T), RS1014702398 (X:49162779 G>C,T), RS1016315731 (X:49166453 G>A), RS1016657726 (X:49168020 T>C,G), RS1016778239 (X:49165975 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation, increases methylation | 2 |
| Smoke | increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| aminomethylphosphonic acid (AMPA) | decreases expression | 1 |
| cinnamaldehyde | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases methylation | 1 |
| Coal | increases abundance, increases expression | 1 |
| Lead | increases expression | 1 |
| Methotrexate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Niclosamide | increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.